133 related articles for article (PubMed ID: 14670229)
1. Targeting of lipid-protamine-DNA (LPD) lipopolyplexes using RGD motifs.
Harvie P; Dutzar B; Galbraith T; Cudmore S; O'Mahony D; Anklesaria P; Paul R
J Liposome Res; 2003 Nov; 13(3-4):231-47. PubMed ID: 14670229
[TBL] [Abstract][Full Text] [Related]
2. Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery.
Kibria G; Hatakeyama H; Ohga N; Hida K; Harashima H
J Control Release; 2011 Jul; 153(2):141-8. PubMed ID: 21447361
[TBL] [Abstract][Full Text] [Related]
3. Lipopolyplex ternary delivery systems incorporating C14 glycerol-based lipids.
Kudsiova L; Fridrich B; Ho J; Mustapa MF; Campbell F; Welser K; Keppler M; Ng T; Barlow DJ; Tabor AB; Hailes HC; Lawrence MJ
Mol Pharm; 2011 Oct; 8(5):1831-47. PubMed ID: 21815622
[TBL] [Abstract][Full Text] [Related]
4. In vivo efficacy of folate-targeted lipid-protamine-DNA (LPD-PEG-Folate) complexes in an immunocompetent syngeneic model for breast adenocarcinoma.
Bruckheimer E; Harvie P; Orthel J; Dutzar B; Furstoss K; Mebel E; Anklesaria P; Paul R
Cancer Gene Ther; 2004 Feb; 11(2):128-34. PubMed ID: 14671672
[TBL] [Abstract][Full Text] [Related]
5. Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells.
Chen CW; Lu DW; Yeh MK; Shiau CY; Chiang CH
Int J Nanomedicine; 2011; 6():2567-80. PubMed ID: 22128247
[TBL] [Abstract][Full Text] [Related]
6. High gene delivery in tumor by intratumoral injection of tetraarginine-PEG lipid-coated protamine/DNA.
Fujita T; Furuhata M; Hattori Y; Kawakami H; Toma K; Maitani Y
J Control Release; 2008 Jul; 129(2):124-7. PubMed ID: 18513820
[TBL] [Abstract][Full Text] [Related]
7. Integrin alphaVbeta3 targeted gene delivery using RGD peptidomimetic conjugates with copolymers of PEGylated poly(ethylene imine).
Merkel OM; Germershaus O; Wada CK; Tarcha PJ; Merdan T; Kissel T
Bioconjug Chem; 2009 Jun; 20(6):1270-80. PubMed ID: 19476331
[TBL] [Abstract][Full Text] [Related]
8. Development of High-Functionality and -Quality Lipids with RGD Peptide Ligands: Application for PEGylated Liposomes and Analysis of Intratumoral Distribution in a Murine Colon Cancer Model.
Suga T; Kato N; Hagimori M; Fuchigami Y; Kuroda N; Kodama Y; Sasaki H; Kawakami S
Mol Pharm; 2018 Oct; 15(10):4481-4490. PubMed ID: 30179010
[TBL] [Abstract][Full Text] [Related]
9. Lyophilization of cationic lipid-protamine-DNA (LPD) complexes.
Li B; Li S; Tan Y; Stolz DB; Watkins SC; Block LH; Huang L
J Pharm Sci; 2000 Mar; 89(3):355-64. PubMed ID: 10707016
[TBL] [Abstract][Full Text] [Related]
10. [Transfection efficiency comparison of cationic liposome-DNA complexes and lipid-protamine-DNA complexes in vitro].
Sun X; Tian L; Nie Y; Zhang Z; Lu J; Wei Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Feb; 24(1):191-5. PubMed ID: 17333920
[TBL] [Abstract][Full Text] [Related]
11. Uptake and transfection efficiency of PEGylated cationic liposome-DNA complexes with and without RGD-tagging.
Majzoub RN; Chan CL; Ewert KK; Silva BF; Liang KS; Jacovetty EL; Carragher B; Potter CS; Safinya CR
Biomaterials; 2014 Jun; 35(18):4996-5005. PubMed ID: 24661552
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of four-arm poly(ethylene glycol)-based gene delivery vehicles coupled to integrin and DNA-binding peptides.
Moore NM; Barbour TR; Sakiyama-Elbert SE
Mol Pharm; 2008; 5(1):140-50. PubMed ID: 18076138
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell targeted liposomes-protamine-DNA complexes mediated by synthetic mannosylated cholesterol as a potential carrier for DNA vaccine.
Li P; Chen S; Jiang Y; Jiang J; Zhang Z; Sun X
Nanotechnology; 2013 Jul; 24(29):295101. PubMed ID: 23799649
[TBL] [Abstract][Full Text] [Related]
14. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
15. Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles.
Rangger C; Helbok A; von Guggenberg E; Sosabowski J; Radolf T; Prassl R; Andreae F; Thurner GC; Haubner R; Decristoforo C
Int J Nanomedicine; 2012; 7():5889-900. PubMed ID: 23226020
[TBL] [Abstract][Full Text] [Related]
16. PEG/RGD-modified magnetic polymeric liposomes for controlled drug release and tumor cell targeting.
Su W; Wang H; Wang S; Liao Z; Kang S; Peng Y; Han L; Chang J
Int J Pharm; 2012 Apr; 426(1-2):170-181. PubMed ID: 22266537
[TBL] [Abstract][Full Text] [Related]
17. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.
Mei L; Fu L; Shi K; Zhang Q; Liu Y; Tang J; Gao H; Zhang Z; He Q
Int J Pharm; 2014 Jul; 468(1-2):26-38. PubMed ID: 24709209
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of polyethylene glycol (PEG)-modified cationic liposome-mediated gene deliveries: effects on serum stability and transfection efficiency.
Kim JK; Choi SH; Kim CO; Park JS; Ahn WS; Kim CK
J Pharm Pharmacol; 2003 Apr; 55(4):453-60. PubMed ID: 12803766
[TBL] [Abstract][Full Text] [Related]
19. Association of albumin or protamine to lipoplexes: enhancement of transfection and resistance to serum.
Faneca H; Simões S; Pedroso de Lima MC
J Gene Med; 2004 Jun; 6(6):681-92. PubMed ID: 15170739
[TBL] [Abstract][Full Text] [Related]
20. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins.
Oba M; Fukushima S; Kanayama N; Aoyagi K; Nishiyama N; Koyama H; Kataoka K
Bioconjug Chem; 2007; 18(5):1415-23. PubMed ID: 17595054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
